Trials / Completed
CompletedNCT03286088
Mitral Valve Regurgitation Quantification From 3D Color Doppler Ultrasound - Standard of Care Data Collection
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Philips Electronics Nederland B.V. acting through Philips CTO organization · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The study primarily aims to collect standard of care clinical data in a wide spectrum of simple to complex mitral valve regurgitation (MVR) cases to validate a post-processing stand-alone software prototype (QFlow), developed by Philips Research Paris (Medisys). Investigator does not intervene in the care of the patient, but simply collects standard of care images and measurements that are needed for the validation of the investigational software.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | TransEsophageal Echocardiography and TransEsophageal Echocardiography | imaging as standard practice |
| DIAGNOSTIC_TEST | Cardiac Magnetics Resonance | imaging as standard practice |
| DIAGNOSTIC_TEST | MitraClip | imaging as standard practice |
Timeline
- Start date
- 2017-08-22
- Primary completion
- 2019-07-31
- Completion
- 2019-12-31
- First posted
- 2017-09-18
- Last updated
- 2021-10-27
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03286088. Inclusion in this directory is not an endorsement.